Reading HUN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HUN free→Reading HUN? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track HUN free→
NYSEMaterialsChemicalsSnapshot 2026-06-15
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is weak, and the company was unprofitable over the past year, so its earnings quality can't be assessed. Management's recent track record has been fairly steady, and risk is elevated. The sector backdrop is a headwind, and compared with sector peers, it is typical. Peer multiples imply a price about 7% above where it trades (it looks cheap on this basis); the read is fair, but weakening. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 3 valuation methods, at three horizons. Current price $15.89. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $16 HUN trades at 1× p/s, below its 1× p/s peer median. Our $17 fair value sits above the price; low confidence. Analysts: $9.00–$15. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price implies about 9% below a flat-multiple fair value, in line with our forecast of about -4%. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
No fragility gates fired. Regime (Crisis) does not concentrate fragility.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 1 of the last 3 quarter-over-quarter moves. Historically, Materials names rated weak grew net income 51% of the time over the next year (vs 59% for the rest of the cohort, n=1088).
Over the trailing year it converted -0.66x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
Not enough signal yet.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $-0.07 → $0.06 (+187.2% / 30d). 9 raised, 0 cut, 12 covering analysts.
0 upgrades, 0 downgrades / 30d. 7% of analysts rate Buy.
1 PT revisions / 30d. Avg target 12.5% above current price.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$231.
How much price usually moves either way.
On a bad day, this stock has moved -$546.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $3,705.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
risk label changed from 'high' to 'elevated'.
As of June 15, 2026, risk rose, changing from a high label to an elevated label. The sector backdrop remains a headwind, indicating ongoing challenges in the environment. Recent financial performance is noted as weak, and earnings quality is described as loss-making. The overall valuation is fair but weakening, reflecting concerns about recent financials.
as of 2026-06-15
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: A positive change in sector revenue growth could signal a recovery for Huntsman Corp.
Confirms:Sector revenue growth turns positive after being near -1 percent for three years.
Disproves:Sector revenue growth remains negative or worsens.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for HUN yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
Results of Operations and Financial Condition. On April 30, 2026, we issued a press release announcing our results for the three months ended March 31, 2026. The press release is furnished herewith as Exhibit 99.1. We will hold a conference call to discuss our first quarter 2026 financial results on Friday, May 1, 2026, at 10:00 a.m. ET. Webcast link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=CrqpAfyY Participant dial-in numbers: Domestic callers: (877) 402-8037 Internati…
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
$9.00 – $15.00 (median $14.00) · 5 analysts · as of 2026-05-19
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Roughly priced in line with peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Diversified Chemicals.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
HUN Huntsman Corp | Typical Show detailsSector percentile: 62 of 100 | fair | elevated |
CBT Cabot Corp | Above typical Show detailsSector percentile: 99 of 100 | inexpensive | moderate |
CC Chemours | Below typical Show detailsSector percentile: 11 of 100 | full | high |
ASH Ashland Global | Typical Show detailsSector percentile: 63 of 100 | fair | moderate |
OLN Olin Corporation | Typical Show detailsSector percentile: 62 of 100 | inexpensive | elevated |
Not investment advice. As of 2026-06-15.
via XLB
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-15.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Focus on enhancing profitability by implementing worldwide pricing strategies.
Newly stated in 2026-Q1. The company expects increased profitability through pricing initiatives, but financials show a net income of -$53 million and operating income of -$16 million in 2026-Q1, indicating limited progress so far.
“We anticipate a step up in profitability with margin expansion from pricing initiatives.”
Maintain capital expenditures between $170 million and $180 million for fiscal year 2025.
Stated in 2 of last 2 quarters. The company aimed to manage capex within $170M-$180M for 2025. However, no specific capex figures for 2025 are provided in the financials, making it difficult to assess delivery against this target.
“We expect to spend between approximately $170 million to $180 million on capital expenditures.”
“We expect to spend between approximately $180 million to $190 million on capital expenditures.”
Focus on improving cash flow from operations to support financial stability.
Newly stated in 2026-Q1. Despite the focus on enhancing cash flow, the company reported cash from operations of -$53 million in 2026-Q1, indicating a negative cash flow and limited progress in this area.
Why it matters: This report will show if the company can improve its weak momentum and financials.
Confirms one read:Q2 earnings report shows revenue growth turning positive year over year.
Confirms the other:Q2 earnings report shows revenue continuing to decline year over year.
Results of Operations and Financial Condition. On February 17, 2026, we issued a press release announcing our results for the three months and year ended December 31, 2025. The press release is furnished herewith as Exhibit 99.1. We will hold a conference call to discuss our fourth quarter and full year 2025 financial results on Wednesday, February 18, 2026, at 10:00 a.m. ET. Webcast link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=IMeg0PNW Participant dial-in numbers: Dom…
Entry into a Material Definitive Agreement. On February 9, 2026, Huntsman International LLC (“HI”), a wholly-owned subsidiary of Huntsman Corporation, entered into a Credit Agreement with Citibank, N.A., as Administrative Agent and Collateral Agent, and the lenders thereto, in connection with an $800 million senior secured revolving credit facility (the “Credit Agreement”). HI may increase the credit facility commitments by up to $400 million, plus additional amounts, subject to certain lever…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information included in
Termination of a Material Definitive Agreement. In connection with entering into the Credit Agreement, on February 9, 2026, HI terminated all commitments and repaid all obligations under HI’s existing credit agreement, dated as of May 20, 2022, among HI, Citibank, N.A., as Administrative Agent, and the lenders party thereto (as previously amended, restated, amended and restated, supplemented or otherwise modified).
“We are focused on enhancing cash flow from operations.”